Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 | Hernandez Steven DennisChief Human Resources Officer | Tax withholding | F | $105K 2,858 sh |
| Mar 16, 2026 traded Mar 15, 2026 |
| 15 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Option exercise | M | $6.70M 112.4K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 15 | Walsh Mark T.Director, CEO & Director | Option exercise | M | $269K 33.5K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 15 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Option exercise | M | $4.69M 78.7K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 15 | Pelish Henry E.Chief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $30K 306 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 15 | Adamson Philip B.Chief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $9,973 1,262 sh | Mar 16, 2026 traded Mar 2, 2026 |
| 15 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $363K 8,303 sh | Mar 16, 2026 traded Mar 11, 2026 |
| 15 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Option exercise | M | $4.69M 78.7K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 15 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Option exercise | M | $6.70M 112.4K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 14 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Option exercise | M | — 78.7K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 14 | Pelish Henry E.Chief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $79K 804 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 14 | Tanious Jubran N.President & COO | Grant or award | A | $1.20M 153.5K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 14 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Option exercise | M | — 112.4K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 14 | Pelish Henry E.Chief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $170K 1,703 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 14 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Option exercise | M | — 5,191 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 14 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Option exercise | M | — 23.9K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Rosen TamiDirector, Chief Development Officer | Option exercise | M | — 15.6K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Smith Victor RemonSenior Vice President | Grant or award | A | — 2,451 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Vincent George H.Executive Vice President | Grant or award | A | — 850 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Kelley Joseph MichaelSenior Vice President | Grant or award | A | — 2,941 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Oddie Andrew DavidCHIEF INTERNATIONAL OFFICER | Option exercise | M | — 12.6K sh | Mar 16, 2026 traded Mar 13, 2026 |
| 13 | Gilligan SarahChief Sup Chn & Transform Ofcr | Tax withholding | F | $29K 1,233 sh | Mar 16, 2026 traded Mar 14, 2026 |
| 13 | O'Brien JennieSVP, Chief Accounting Officer | Grant or award | A | — 9,917 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Kozlik ChristenChief Accounting Officer | Option exercise | M | — 1,875 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 13 | Perros EvangelosChief Financial Officer | Option exercise | M | — 20.6K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Reed Timothy R.EVP, R&D and Tour | Option exercise | M | — 11.4K sh | Mar 16, 2026 traded Mar 14, 2026 |
| 13 | Crow David MEVP, Head of Axos Clearing | Option exercise | M | — 738 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 13 | Wagner AdamSee remarks | Option exercise | M | — 15.7K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Zalatoris TimmiChief Human Resources Officer | Grant or award | A | — 1,908 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Bothwick Jay EDirector | Option exercise | M | — 625 sh | Mar 16, 2026 traded Mar 14, 2026 |
| 13 | Gill AnnSVP, Chief Accounting Officer | Option exercise | M | — 675 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 13 | Simhambhatla RaviEVP, CDIO - see remarks | Option exercise | M | — 2,394 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Newcomb Matthew SChief Financial Officer | Grant or award | A | — 140.7K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Seger Brett A.Chief Accounting Officer | Tax withholding | F | $7,544 1,595 sh | Mar 16, 2026 traded Mar 14, 2026 |
| 13 | Weigensberg AryeSee Remarks | Option exercise | M | — 26.8K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Hamilton DustinChief Stores Officer | Grant or award | A | — 2,445 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Nichols Brian WGroup VP & Controller | Grant or award | A | — 921 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Cerwin Brittany CChief Accounting Officer | Grant or award | A | — 1,807 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 13 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $915K 22.2K sh | Mar 16, 2026 traded Mar 13, 2026 |
| 13 | Fuchsen Matthew RChief Development Officer | Grant or award | A | — 2,345 sh | Mar 16, 2026 traded Mar 13, 2026 |